메뉴 건너뛰기




Volumn 20, Issue 5 C, 2000, Pages 3647-3655

A phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma

Author keywords

Antibody; Immunotherapy; Lym 1; Lymphoma; Radiation

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; 2 [4 (BROMOACETAMIDO)BENZYL] DOTA; 2 IMINOTHIOLANE; ANTINEOPLASTIC AGENT; CHELATING AGENT; COPPER 67; IMINOTHIOL; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LYM 1; UNCLASSIFIED DRUG; YTTRIUM 90;

EID: 0034532254     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (46)

References (42)
  • 21
    • 85078982526 scopus 로고
    • Radiochemistry of therapeutic radionuclides
    • Cancer Therapy with Radiolabeled Antibodies. (Goldenberg, DM, ed). Boca Raton, FL, CRC Press
    • (1995) , pp. 47-61
    • Griffiths, G.L.1
  • 32
    • 0003562305 scopus 로고
    • Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation, part 2
    • New York, Society of Nuclear Medicine
    • (1970) MIRD Pamphlet No. 6
    • Dillman, L.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.